Importantly, both ALDH knockout and 673A treatment of ovarian cancer cell lines synergized with DNA damage checkpoint inhibitors, AZD1390 (ATM inhibitor) and AZD6738 (ATR inhibitor), resulting in a synergistic decrease in cell viability in vitro and tumor growth in vivo. Here, ATR is linked to ovarian cancer.